| Nov 18 |
Why This Beaten-Down Dividend Stock Is a No-Brainer Buy on the Dip
|
| Nov 18 |
AbbVie Receives European Commission Approval of ELAHERE® (mirvetuximab soravtansine) for the Treatment of Platinum-Resistant Ovarian Cancer
|
| Nov 17 |
Super Micro Computer, Moderna And XPeng Were Among Top 10 Large Cap Stocks Losing Big Last Week (November 11-15): Check Out Other Losers
|
| Nov 17 |
AbbVie's (NYSE:ABBV) Shareholders Will Receive A Bigger Dividend Than Last Year
|
| Nov 16 |
Why AbbVie’s (ABBV) Drug Setback Creates A Prime Buy-The-Dip Moment
|
| Nov 15 |
Pharma Stock Roundup: AZN, BAYRY's Earnings, ABBV's Pipeline Setback
|
| Nov 15 |
U.S. Pharma is largely immune from 'MAHA' impact: Wolfe
|
| Nov 15 |
AbbVie Stock Falls 11% in a Month: Should You Buy the Dip?
|
| Nov 15 |
AbbVie, Bitcoin And An Energy Stock On CNBC's 'Final Trades'
|
| Nov 15 |
Got $1,500 to Invest? AbbVie Just Proved the Bull Thesis for Its Stock
|
